Vanda Pharmaceuticals Inc. (VNDA) Financials
VNDA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 648.4 million | 103.5 million |
2023-09-30 | 641.6 million | 98.5 million |
2023-06-30 | 641.7 million | 101.8 million |
2023-03-31 | 644.5 million | 108.8 million |
VNDA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -4.0 million | 3.3 million |
2023-09-30 | -2.1 million | 3.2 million |
2023-06-30 | -13.3 million | 3.2 million |
2023-03-31 | 31.8 million | 4.4 million |
VNDA Net Income
No data available :(
VNDA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 388.3 million | - | 9.4 million |
2023-09-30 | 489.9 million | - | 7.5 million |
2023-06-30 | 489.4 million | - | 7.9 million |
2023-03-31 | 501.5 million | - | 10.7 million |
VNDA Shares Outstanding
VNDA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 253000 | 24.3 million | 23.6 million | - |
2023-09-30 | 24000 | 16.6 million | 24.8 million | - |
2023-06-30 | 55000 | 16.6 million | 28.4 million | - |
2023-03-31 | 51000 | 19.2 million | 36.1 million | - |
VNDA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 45.3 million | 3.5 million |
2023-09-30 | 38.8 million | 3.1 million |
2023-06-30 | 46.1 million | 3.5 million |
2023-03-31 | 62.5 million | 4.8 million |
VNDA
Price: $4.68
52 week price:
Earnings Per Share: 0.04 USD
P/E Ratio: 16.52
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 456204
Ebitda: -1.4 millionMarket Capitalization: 259.5 million